Consolidated Statement of Cash Flows

IR

Consolidated Statement of Cash Flows

(Million yen)

 
FY2020
(as of December 31,
2020)
FY2021
(as of December 31,
2021)
Cash flows from operating activities  
 
Profit before income taxes 6,360 7,606
Depreciation 268 219
Amortization of goodwill 201 207
Increase (decrease) in allowance
for doubtful accounts 
2 (43)
Increase (decrease) in provision for
bonuses
21 37
Increase
(decrease) in
allowance for
subscription
cancellations
12 (24)
Interest and dividends income (3) (3)
Interest expenses 7 7
Share of loss (profit) of entities
accounted for using equity method
(163) (26)
Loss on retirement of non-current assets 17 22
Loss (gain) on sale of investment
securities
(250) (20)
Loss (gain) on valuation 
investment securities
10 0
Loss on COVID-19 62 37
Decrease (increase) in trade receivables 93 (1,414)
Decrease (increase) in inventories 23 3
Decrease (increase) in accounts receivable-other (5) 85
Increase (decrease) in trade payables (117) 341
Increase (decrease) in
accrued expenses
(7) 301
Increase (decrease) in
accrued consumption taxes
1 519
Increase (decrease) in
accrued expenses
(7) 301
Increase (decrease) in
accrued consumption taxes
1 519
Increase (decrease) in accrued
enterprise taxes
(86) 38
Increase (decrease) in
retirement benefit liability
62 56
Other, net 80 49
Subtotal 6,587 7,996
Interest and dividends 
received
32 45
Interest 
paid
(7) (7)
Payment of loss on COVID-19 (54) (34)
Income taxes paid (2,580) (1,639)
Income taxes refund 1 7
Net cash provided by (used in) operating
activities
3,979 6,368

(Million yen)

 
FY2020
(as of December 31,
2020)
FY2021
(as of December 31,
2021)
Cash flows from investing activities  
 
Purchase of property,
plant and equipment
(150) (52)
Purchase of intangible assets (129) (127)
Proceeds from sales of investment
securities
416 20
Purchase of shares of subsidiaries
resulting in change in scope of
consolidation
(18)
Payments for sales of shares of
subsidiaries resulting in change in
scope of consolidation
(233)
Proceeds from collection of
loans receivable
18 45
Proceeds from cancellation of
insurance funds
17
Other, net (9) 14
Net cash provided by (used in) investing
activities
(89) (99)
Cash flows from financing activities  
 
Repayments of long-term borrowings (80)
Purchase of treasury shares (995) (554)
Dividends paid (1,476) (1,571)
Other, net (2) 37
Net cash provided by (used in) financing
activities
(2,472) (2,168)
Net increase (decrease)
in cash and cash equivalents
1,418 4,101
Cash and cash equivalents
at beginning of the period
11,811 13,309
Increase in cash and cash equivalents
resulting from inclusion of subsidiaries
in consolidation
80
Cash and cash equivalents
at end of the period
13,309 17,410

ARCHIVE